Home › Cardiomyopathy › Missouri
Cardiomyopathy clinical trials in Missouri
9 studies for Cardiomyopathy are looking for participants at sites in Missouri.
Cities in Missouri
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- St. Luke's Hospital, Kansas City
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Nov 4, 2026 · NCT06128629TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, St Louis
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Oct 20, 2026 · NCT07052903Danon Disease Natural History Study
- Washington University, St Louis
RecruitingObservational study
Ages 8 and older · All sexes · Updated Oct 19, 2026 · NCT06214507Clinical Course Of Disease In Participants With FA-CM
- Washington University School of Medicine in St. Louis, St Louis
RecruitingObservational study
Ages 6 and older · All sexes · Updated Oct 19, 2026 · NCT06865482DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT07358078ATR 1072 in Participants With PRKAG2 Syndrome
- St Luke's Mid American Heart Institute, Kansas City
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 18, 2026 · NCT07738107Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- St. Luke's Hospital of Kansas City, Kansas City
- Washington University in St. Louis, St Louis
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
- Washington University in St. Louis, St Louis
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Jul 29, 2026 · NCT07695701Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- University of Mossouri, Columbia
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2025 · NCT06964464From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.